Ian Shakil, CHIEF STRATEGY OFFICER at Augmedix, Inc. (AUGX), sold 187,250 shares at $3.89 ($729K) on 2024-04-01, disclosed to the SEC on 2024-04-03.
Open-market sale of $729k AUGX by CHIEF STRATEGY OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.89 | 51,346 | $200K | 27.4% |
| 2 | $3.89 | 51,346 | $200K | 27.4% |
| 3 | $4.02 | 7,632 | $31K | 4.2% |
| 4 | $3.89 | 38,463 | $150K | 20.5% |
| 5 | $3.89 | 38,463 | $150K | 20.5% |
| Total | $3.90 avg | 187,250 |
| $729K |
| 100% |
| Filing → |
| AUGX | SELL | 2024-04-15 | $149K | — | Filing → |
| AUGX | SELL | 2024-04-11 | $738K | — | Filing → |
| AUGX | SELL | 2024-04-09 | $678K | — | Filing → |